Related Experiment Video
Updated: Jul 11, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression
Patricia J Champine1, Jacob Michaelson, Bart C Weimer
1Center for Integrated BioSystems, Utah State University, Logan, UT 84322-4700, USA.
Abstract:
We used Affymetrix microarrays to compare gene expression profiles of the metastatic parental breast cancer cell line MDA-MB-435 (435) and the non-metastatic daughter cell line created by the stable expression of the BReast cancer Metastasis Suppressor 1 (BRMS1) gene in 435 cells, MDA-MB-435-BRMS1 (435/BRMS1). Analysis of microarray data provided insight into some of the potential mechanisms by which BRMS1 inhibits tumor formation at secondary sites. Furthermore, due to the importance of the microenvironment, we also examined gene expression under different growth conditions (i.e., plus or minus serum). Expression of 565 genes was significantly (adjusted P-value <0.05) altered regardless of in vitro growth conditions. BRMS1 expression significantly increased multiple major histocompatability complex (MHC) genes and significantly decreased expression of several genes associated with protein localization and secretion. The pattern of gene expression associated with BRMS1 expression suggests that metastasis suppression may be mediated by enhanced immune recognition, altered transport, and/or secretion of metastasis-associated proteins.
Insights
The BReast cancer Metastasis Suppressor 1 (BRMS1) gene inhibits breast cancer metastasis by enhancing immune recognition and altering protein transport and secretion pathways. This study compared gene expression in metastatic and non-metastatic cell lines.
Area of Science:
- Molecular Biology
- Cancer Research
- Genomics
Background:
- Breast cancer metastasis is a complex process involving genetic alterations.
- The BReast cancer Metastasis Suppressor 1 (BRMS1) gene is known to inhibit metastasis.
- Understanding the molecular mechanisms of BRMS1 is crucial for developing targeted therapies.
Purpose of the Study:
- To compare gene expression profiles between metastatic and non-metastatic breast cancer cell lines.
- To elucidate the mechanisms by which BRMS1 suppresses tumor metastasis.
- To investigate the influence of microenvironment on gene expression modulated by BRMS1.
Main Methods:
- Affymetrix microarrays were used to analyze gene expression profiles.
- Two breast cancer cell lines were compared: MDA-MB-435 (metastatic) and MDA-MB-435-BRMS1 (non-metastatic).
- Gene expression was analyzed under different in vitro growth conditions (with and without serum).
Main Results:
- The expression of 565 genes was significantly altered by BRMS1, irrespective of growth conditions.
- BRMS1 significantly upregulated multiple major histocompatability complex (MHC) genes.
- BRMS1 significantly downregulated genes associated with protein localization and secretion.
Conclusions:
- BRMS1-mediated metastasis suppression may involve enhanced immune recognition.
- Altered protein transport and/or secretion pathways are implicated in BRMS1's function.
- Gene expression analysis provides insights into the molecular underpinnings of metastasis suppression by BRMS1.
